Resveratrol is a compound produced by many plants; it is found in grape skins and, consequently, red wine. Resveratrol serves as a plant's protective mechanism against bacteria and fungi. Scientific studies show that these protective abilities of resveratrol likely benefit human health as well. However, the advice of a medical professional should be sought before trying to prevent, treat or cure any condition with resveratrol.
Colorectal Cancer
Resveratrol may help people with colorectal cancer. For men and women in the United States, colorectal cancer is the fourth most prevalent form of cancer. A study of patients with colorectal cancer, published in October 2010 in "Cancer Research," revealed that resveratrol has the ability to stop the spread of tumor cells. The resveratrol did not lead to any notable side effects among patients. The participants were given dosages of both 500 mg and 1,000 mg, both of which lead to cancer cell reduction.
Pancreatic Cancer
Resveratrol shows promising evidence as a treatment for pancreatic cancer, a type of cancer that rapidly advances. Compounds that can reduce the spread of the pancreatic cancer cells may be an important consideration. A study published in December 2010 in "Cancer Research" found that resveratrol was able to inhibit the formation of tumors in rats with pancreatic cancer.
Heart Failure
Heart failure is one of the largest causes of death in the United States. Resveratrol may be a beneficial compound for preventing heart disease. Scientific evidence shows that resveratrol may have heart-protective properties, according to an article published in January 2010 in "Current Chemical Biology". Specifically, resveratrol has been related to reversals in heart structure damage.
Fanconi Anemia
Of the rare genetic bone disorders, fanconi anemia is the most widely reported. The condition leads to the breakdown of bone marrow. Bone marrow is the source of production of a variety of blood cells. Resveratrol may be useful for treating progressive bone marrow failure in fanconi anemia patients. A study of mice, published in December 2010 in "Blood," found that resveratrol helped preserve bone marrow cells from rapid turnover and improved the environment of the bone marrow cells.
References
- "Cancer Research"; Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients; Ketan R. Patel et al.; October 2010
- "Cancer Research"; Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase; Naomi Oi et al.; December 2010
- "Current Chemical Biology"; Potential of Resveratrol in Preventing the Development of Heart Failure; Peter Wojciechowski et al.; January 2010
- "Blood"; Fancd2-/- Mice Have Hematopoietic Defects That Can Be Partially Corrected by Resveratrol; Q.S. Zhang et al.; December 2010
Member Comments